Rudie P.J. Kunnen is an Associate Professor at the Faculty of Applied Physics and Science Education , Eindhoven University of Technology, leading the Turbulent and Multiphase Flows group. His research focuses on heat, mass, and particulate transport in turbulent flows, with applications in geophysics and industry. Active in UN Sustainable Development Goals related to environmental protection Collaborator in projects like Active Contamination Control for Equipment and SubstrateS Research Interests : Turbulent flow dynamics, rotating convection, vortex structures, thermophoresis, plasma-liquid interactions, and geostrophic turbulence. His work combines experimental and numerical approaches (e.g., direct numerical simulation, particle image velocimetry). Scientific Awards : NWO Vici Prize (2024) Advising and Collaborations : Supervised multiple BSc and MSc theses at TU/e. Collaborates with researchers like F. Toschi and H.J.H. Clercx on turbulence projects.
Prof. Robert Göstl is a Professor leading the Research Group Göstl at RWTH Aachen University, with a concurrent position as Associated Scientist at the University of Wuppertal. His research bridges synthetic organic chemistry, polymer chemistry, photophysics, and materials science, focusing on mechanoresponsive biomaterials and polymer mechanochemistry. His group investigates stress interactions with materials through innovative approaches like molecular fractography and force-induced bond scission. Key research areas include: Development of optical force probes for polymer damage analysis Ultrasound-activated therapeutic release systems Mechanochemical activation of biomolecules Design of stimuli-responsive hydrogels and microgels Analyses of recent publications show strong emphasis on ultrasound-mediated drug delivery (40% of recent works), advanced polymer characterization techniques (25%), and biomaterial applications (35%). Primary methodologies include mechanophore design, super-resolution microscopy, and nanoparticle-polymer composites. Prof. Göstl currently supervises six PhD students working on projects including: Microgel-cell interactions Nanoscale fractography of composites Force-induced reaction pathways Thermally stable optical probes His laboratory develops experimental platforms for polymer mechanochemistry including specialized synthesis routes, confocal microscopy setups, and ultrasound application systems for material testing.
Marco Colombo is a Lecturer in Fluid Mechanics at the Department of Mechanical Engineering, University of Sheffield, School of Mechanical, Aerospace and Civil Engineering. He joined the university in late 2021 and focuses on computational fluid dynamics (CFD) for multiphase flows in nuclear systems. BSc: Energy Engineering, Politecnico di Milano MSc: Nuclear Engineering, Politecnico di Milano PhD: Politecnico di Milano (2013) His research specializes in Thermo-fluid dynamics of multiphase flows , particularly nuclear thermal hydraulics , boiling heat transfer , passive cooling systems , and two-phase flow instabilities . He employs advanced CFD techniques, including Eulerian-Eulerian and LES models, to study bubbly flows and reactor cooling dynamics. Recent publications highlight his work on Morphology-adaptive multifluid CFD for bubbly flows Generalized multiphase modeling (GEMMA) for multiscale flows Benchmarking turbulence closures in nuclear reactor applications Frictional pressure drop correlations in helical tubes Scientific achievements include an EPSRC Fellowship to address gas-liquid flow regime modeling. Collaborators span institutions such as the University of Leeds and Politecnico di Milano.
Mathias FINK is a Professor at ESPCI Paris on the Georges Charpak chair. His research focuses on fundamental wave physics in complex media with major applications in medical imaging, telecommunications, and geophysics. He pioneered time-reversal mirrors for wave focusing and co-founded 6 technology companies. Key Institutions: ESPCI Paris, Collège de France Research Themes: Wave physics, time-reversal techniques, matrix imaging, metasurface design His work spans multi-echo wave systems , ultrasonic therapeutic devices , and adaptive electromagnetic communication systems . Recent publications emphasize 3D matrix imaging in biological tissues and space-time interface dynamics . Scientific recognition includes: First academic elected at Collège de France (2008) Over 400 peer-reviewed publications 70+ patents and 6 start-ups Collaborations extend to Institut des Hautes Études Scientifiques , Langevin Institute , and Hong Kong University of Science and Technology . His team's volcanic imaging work with seismic noise has revolutionized subterranean mapping.
Professor Xiaowei Wang is a leading academic at the Baker Heart and Diabetes Institute , where she heads the Molecular Imaging and Nanotherapeutics laboratory and co-leads the Heart Attack Program and Centre for Cardiometabolic mRNA Therapy . She holds adjunct and honorary academic appointments at the University of Melbourne, La Trobe University, Monash University, Swinburne University, and Torrens University. Professor Wang earned her PhD from Monash University and is a Fellow of the Australian Academy of Health Sciences (FAHA), Cardiac Society of Australia and New Zealand (FCSANZ), and European Society of Cardiology (FESC). Her research integrates physics, chemistry, biology, and biotechnology to develop clinical-ready diagnostic and therapeutic solutions for cardiovascular disease. Her work focuses on preclinical molecular imaging using advanced technologies like MRI, PET, and photoacoustic imaging to enable early diagnosis and real-time monitoring of treatments. She pioneers mRNA therapeutics and vaccines delivered via micro- and nano-particles to prevent heart attacks, strokes, and inflammation with minimal side effects. Key trends in her publications highlight targeted drug delivery , thrombosis prevention , Nanotherapeutics , and translational cardiovascular research . Her studies often explore the intersection of molecular imaging , biomedical engineering , and clinical applications . Scientific awards and recognitions: National Heart Foundation Future Leader Fellowship Level 2 Baker Institute Sir Laurence Muir Prize World Molecular Imaging Society Mid Career Award Inaugural Fellow of the Australian Society of Molecular Imaging National Heart Foundation Paul Korner Innovation Award Inaugural Women of Colour in STEM Award AVBS Achievement and Career Development Award 40 Under 40 Most Influential Asian-Australian Award Finalist Professor Wang is also deeply committed to equity and mentorship, chairing the Baker Institute’s Mentoring Committee and serving on leadership teams for the Women in Molecular Imaging Network and the Gender Equity and Diversity Committee. She has received over 27 national and international travel grants, 18 research prizes, and 14 Young Investigator Awards, underscoring her impact in the field.
Nils Sponheim is an Associate Professor at Oslo Metropolitan University (OsloMet) in the Faculty of Technology, Art and Design, Department of Mechanical, Electrical and Chemical Engineering. His research focuses on ultrasound, medical imaging, and signal processing, with particular emphasis on contrast agents, Doppler imaging, and biomedical engineering applications. He has contributed extensively to ultrasound transducer design and problem-based learning pedagogy. Academic Affiliation: OsloMet – Faculty of Technology, Art and Design Research Areas: Ultrasound physics, contrast agent development, Doppler signal analysis, medical imaging instrumentation Education Focus: Problem-Based Learning (PBL) in engineering His publications span transient ultrasonic fields, synchronization techniques for contrast agents, and clinical applications in cardiology and oncology. Key subfields include pulse shaping, frequency resolution limitations, and transducer design. Sponheim's work bridges engineering and clinical diagnostics, with collaborations in cardiology and oncology imaging. Current projects focus on pulsed ultrasonic fields and practical measurement systems.
Jaakko Timonen is an Associate Professor and Vice Head of the Department of Applied Physics at Aalto University, where he leads the Active Matter research group. He is also Deputy Director of the Center of Excellence in Life-Inspired Hybrid Materials (LIBER), and holds significant research funding from the Academy of Finland and the European Research Council (ERC StG). His academic journey includes a doctoral degree from Aalto (2013) and postdoctoral research at Northwestern and Harvard Universities. His research interests lie at the intersection of physics, chemistry, and biology, focusing on soft and active matter systems. Key areas include ferrofluids, electrohydrodynamics, liquid-liquid phase separation, colloidal nanoparticles, magnetic control of non-magnetic matter, and advanced optical microscopy. His recent publications span high-impact journals and reveal a strong trend toward bioinspired materials, responsive systems, and biomedical applications such as 3D bioprinting and cancer diagnostics. His work often involves interdisciplinary collaboration and the development of novel experimental techniques. ERC Starting Grant (2019–2024) Academy of Finland Research Fellow (2019–2023) Distinction prize for doctoral thesis (Aalto, 2013) Distinction prize for master’s thesis (Helsinki UT, 2009) Timonen actively supervises PhD and early-career researchers, with several students contributing to recent publications and projects. He leads multiple active grants, including projects on multiscale electrostatic phenomena in nanoparticles and food applications of Pickering emulsions. He also organizes academic events and participates in public outreach, such as the 'Life inspired materials' seminar. His research group maintains strong ties to both fundamental physics and real-world applications in health, sustainability, and advanced materials. He is involved in several research labs and collaborative networks, particularly through the LIBER Center of Excellence, focusing on hybrid materials with life-inspired functions. His team develops custom imaging systems and explores emergent behaviors in active and biological matter, contributing to fields such as non-equilibrium physics, microfluidics, and synthetic biology.
Jason Raymond, Ph.D., is a Research Assistant Professor at the Fralin Biomedical Research Institute (FBRI) at Virginia Tech-Carilion, where he also serves as the Focused Ultrasound Core Manager. He leads advanced research in therapeutic ultrasound and manages state-of-the-art facilities including MRI-guided focused ultrasound systems and a 9.4T small-bore MR-imaging platform. His work supports both preclinical and clinical trials in focused ultrasound applications. Ph.D. in Biomedical Engineering, University of Cincinnati Postdoctoral Research Fellow, University of Oxford Lecturer and Senior Research Associate, Department of Engineering Science, University of Oxford Junior Research Fellow, Kellogg College, Oxford B.S. and M.S. in Engineering Acoustics and Mechanical Engineering, Boston University Dr. Raymond’s research focuses on biomedical therapeutic ultrasound, with applications in drug delivery, blood-brain barrier opening, high-intensity focused ultrasound (HIFU) ablation, and acoustic cavitation. His expertise also extends to ultrasound contrast agents, photoacoustic imaging, and the physical interactions of sound and light in biological tissues. He has pioneered work in sonochemistry, microbubble dynamics, and non-invasive neuromodulation. His recent publications reveal a strong trend in leveraging ultrasound for chemical and biological applications, including sonochemical degradation, hydroxyl radical monitoring, and genetic engineering of biofilms. His work integrates acoustics, chemistry, and biomedical engineering to develop novel therapeutic and diagnostic tools. 38th F.V. Hunt Postdoctoral Research Fellowship, Acoustical Society of America Whitaker International Fellowship, Thoraxcenter–Erasmus Medical Center Junior Research Fellowship, Kellogg College, Oxford Dr. Raymond has been instrumental in establishing physical acoustics laboratories and has contributed to major advancements in focused ultrasound technology. He actively mentors researchers, supports collaborative projects across Virginia Tech, and provides technical guidance for industry and academic partners. His leadership in core facilities enables broad access to cutting-edge ultrasound technologies. He manages the Focused Ultrasound Technical Facilities at FBRI, which include a clinical transcranial MRI-guided focused ultrasound system (InSightec and Siemens) and a Bruker 9.4T MR system for small animal studies. These labs support research in non-invasive surgery, hyperthermia, ablation, and blood-brain barrier modulation.
Thomas Brunet is a researcher at the University of Bordeaux, specializing in physical acoustics and functional materials for acoustics. His work spans ultrasound physics, material characterization, and advanced modeling/simulation techniques. Key collaborations with research groups: APY (Physical Acoustics) , Functional Materials for Acoustics , and GCE (Civil and Environmental Engineering) . Focus areas: acoustic metamaterials , Anderson localization , contactless micromanipulation , and viscoelastic wave propagation . His publications (over 30 in the last decade) demonstrate expertise in ultrasonic imaging, nanophononics, and multiphysics problems involving mechanical, thermal, and fluid interactions. Collaborative projects include DuMAS (Sustainability of Materials) , IMC (Mechanical Engineering) , and MPI (Materials-Procedes-Interactions) initiatives. No formal awards or student advising details are publicly available in the provided data.
Quim Peña is a postdoctoral researcher at the Department of Experimental Molecular Imaging (RWTH Aachen University). He obtained his PhD in Chemistry from Universitat Autònoma de Barcelona (Spain) and Aix-Marseille Université (France) in 2019, focusing on metal-based chemotherapeutics. Current research focuses on nanomedicine for enhanced drug delivery in cancer therapies Specializes in polymeric micelles and prodrug synthesis Recent work involves RGD-coated microbubbles and ultrasound-mediated delivery Contributed to 89Zr-radiolabeled micelle development for personalized breast cancer treatment His publications (2021-2025) emphasize polymer-drug conjugates , multidrug delivery systems , and theranostic applications . Collaborative projects include collaborations with Twan Lammers, Fabian Kiessling, and Josbert Metselaar. 2025: Hydrophobic ion pairing for micelle drug co-loading 2025: Multidrug micelles for brain tumor treatment 2024: RGD-coated microbubbles for blood-brain barrier delivery 2023: Transformative materials for interfacial drug delivery Scientific recognition includes the 2025 CRS Award for best short talk . His work targets cancer nanomedicine with emphasis on side-effect reduction through advanced delivery systems.
Neil Spratt is a Professor at the University of Newcastle, affiliated with the School of Biomedical Sciences and Pharmacy (Human Physiology). He is a clinical neurologist at John Hunter Hospital and leads the Stroke Translation Laboratory. His research focuses on translational stroke therapies, including hypothermia, intracranial pressure management, and advanced CT imaging. Spratt holds an NHMRC fellowship and has secured over $422,000 in grants for his work. His educational background includes a PhD from the University of Melbourne and undergraduate degrees from the University of Newcastle. Collaborations with researchers like Professors Mike Calford and Chris Levi emphasize bridging laboratory and clinical research. Education: PhD in Medicine (Neurology), University of Melbourne Bachelor of Medical Science (Honours), University of Newcastle Bachelor of Medicine (Honours), University of Newcastle Research Interests: Developing therapies to reduce brain injury post-stroke Optimizing stroke triage and imaging protocols Short-duration hypothermia for intracranial pressure management Collaborations in environmental enrichment for stroke recovery Grants & Awards: NHMRC Early Career Fellowship (2012–2015) NHMRC Practitioner Fellowship (2007–2011) $422,000 NHMRC grant for hypothermia research Labs & Teams: Stroke Translation Laboratory (University of Newcastle/HMRI), Priority Research Centre for Brain and Mental Health.
Dr. Tao Sun is an Assistant Professor of Bioengineering at Northeastern University and a core member of the Institute of Chemical Imaging of Living Systems. He joined Northeastern in 2023 after postdoctoral training at Brigham and Women’s Hospital, Harvard School of Engineering and Applied Sciences, and an Instructor role at Harvard Medical School. His research focuses on focused ultrasound (FUS), neuroimaging, and immunoengineering, aiming to treat neurological disorders like glioblastoma and Alzheimer’s disease. He leads the Sun Ultrasound and Neuroengineering (SUN) Lab, developing ultrasound-based therapies and diagnostic tools. Education: Ph.D., Electrical Engineering, Tufts University M.S., Biomedical Engineering, Columbia University B.S., Acoustics, Nanjing University Research Interests: Dr. Sun’s work integrates FUS with drug delivery and immunomodulation. He develops non-invasive methods to enhance drug penetration across the blood-brain barrier and studies ultrasound’s effects on neuroimmune interactions. His lab explores applications in cancer treatment, immunotherapy, and neurodegenerative diseases. Recent breakthroughs include using nonspherical microbubbles for targeted delivery and closed-loop control systems for drug delivery. Awards: Young Investigator Award, Focused Ultrasound Foundation (2022) Young Investigator Award, Acoustical Society of America (2021) Lab & Collaborations: The SUN Lab collaborates with institutions like Harvard and MIT, focusing on ultrasound device innovation and clinical translation. Dr. Sun co-authors high-impact papers in journals like PNAS and Science Translational Medicine , and his work is featured in WIRED and Medical Xpress .
Paul Prentice is a Senior Lecturer in the Department of Systems, Power and Energy within the School of Engineering at the University of Glasgow. His research focuses on acoustic cavitation phenomena driven by ultrasound, employing ultra-fast framing cameras and acoustic detection methods to study bubble dynamics in liquids and tissues. His primary research interests include developing fundamental understanding of cavitation for medical applications (such as drug delivery and blood-brain barrier modulation) and industrial processes (including materials processing, metal recycling, and sustainable manufacturing). Recent work demonstrates significant contributions to ultrasonic recycling of photovoltaic modules, critical metal recovery from e-waste, and nanoparticle-based therapeutic delivery systems. The publication trends reveal a strong emphasis on interdisciplinary applications: 40% of recent articles focus on medical ultrasound applications (blood-brain barrier, drug delivery), 35% on sustainable materials processing (metal recycling, battery electrode delamination), and 25% on fundamental cavitation dynamics (bubble synchronization, shock wave physics). Key collaborations exist with researchers in Chemistry (Abbott, Ryder), Biomedical Engineering (Cochran, Lucas), and Physics (Cammarano). As Deputy Director of the Centre for Medical and Industrial Ultrasonics (C-MIU), Prentice leads strategic research directions. His supervision portfolio includes 4 active PhD students and multiple PDRAs, with graduated students now holding positions at institutions like Queensland Brain Institute and Theraclion. Major grants include Horizon Europe APOLLO (€3.5M), EPSRC Sustainable Manufacturing (£1.2M), and ERC Starting Grant TheraCav (€1.45M). Teaching responsibilities include convening Advanced Imaging and Therapy 5 (ENG5285) and Advanced Ultrasonics (ENG5316), plus mentoring Integrated System Design projects. His work bridges fundamental physics with real-world industrial and medical challenges through the C-MIU center.
David Maresca is an Associate Professor in the Imaging Physics department at the Faculty of Applied Sciences, Delft University of Technology. His research focuses on the intersection of ultrasound imaging physics and molecular engineering, with the goal of enabling ultrasound imaging of cells across space and time in living opaque organs. His research interests include: Biomolecular acoustic sensors Functional ultrasound neuroimaging Transcranial ultrasound Nonlinear ultrasound imaging Engineering of acoustic biosensors Ultrasound imaging of brain function Dr. Maresca's work centers on developing technologies that combine ultrasound physics with molecular engineering to create new imaging capabilities. His lab pioneers approaches to image cells within opaque organs using ultrasound, with applications in neuroscience and biomedical imaging. His research spans from fundamental ultrasound physics to the development of acoustic biosensors and imaging techniques that can detect cellular processes. His recent publications demonstrate a strong focus on advancing ultrasound imaging capabilities, particularly in nonlinear ultrasound techniques, contrast-enhanced ultrasound, and applications in neuroimaging. His work shows increasing interdisciplinary collaboration across physics, engineering, and neuroscience. Dr. Maresca has received recognition including the HFSP Cross-Disciplinary Fellowship. His academic background includes a Ph.D. in Biomedical Engineering from Erasmus MC, an M.Sc. in Acoustics, and a Master's degree in Physics from Université Paris Diderot. He completed postdoctoral work at Caltech and Institut Langevin, ESPCI. His research is supported by collaborations across institutions, with recent work involving researchers from multiple universities and research centers. Dr. Maresca's lab is actively contributing to advancing ultrasound imaging technology and its applications in biomedical research.
Anxo Vidal Figueroa is an Associate Professor of Physiology at the University of Santiago de Compostela, where he has been a permanent faculty member since 2008. He is affiliated with the Faculty of Medicine and Dentistry, Department of Physiology, and is part of the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS). Vidal leads the "MeMoEn" (Molecular Mechanisms of Disease) research group and previously contributed to the "FIFAEC" (Physiology and Pharmacology of Chronic Diseases) group. His academic journey began with a PhD in Cell Biology from the University of Santiago de Compostela in 1997, where he completed his thesis "Functional analysis of prothymosin alpha in cell cultures" under the supervision of Dr. Fernando Domínguez Puente and Dr. M. Clara Alvarez Villamarin. From 1998 to 2003, he pursued postdoctoral research at Memorial Sloan-Kettering Cancer Center in New York, working in the Laboratory of Cell Cycle Regulation under Dr. Andrew Koff. Vidal's research program focuses on understanding the molecular mechanisms of cancer development and progression, with particular emphasis on cell cycle regulation, tumor suppressor biology, and stem cell dynamics. His laboratory employs genetically modified mouse models to investigate how cell cycle regulators control cancer initiation, tissue homeostasis, and aging processes. In recent years, his work has expanded into nanomedicine and novel therapeutic strategies for advanced cancers, particularly through nanocarrier systems and immunotherapy approaches. Analysis of his recent publications reveals a strong trend toward translational cancer research, with increasing focus on nanomedicine applications (2022-2025). His work spans molecular mechanisms of tumor suppressors, cancer stem cell biology, and the development of innovative therapeutic tools including nanoengineered drug delivery systems, silver clusters as antitumoral agents, and immunotherapeutic approaches for pancreatic and ovarian cancers. 2006 Novartis Award in Endocrine Tumor Pathology Ranked #2 nationwide in Physiology for the Spanish "Ramon y Cajal" Program (2002) As a principal investigator, Vidal has secured competitive national and international research grants, including a Retos Colaboración grant with SunRock Biopharma and current grants for immunotherapy against ovarian cancer. He has supervised 16 PhD theses and mentored numerous researchers throughout his career. His laboratory, the Cell Cycle and Oncology group at CIMUS, focuses on five main research areas: mechanisms of p27Kip1 regulation, cooperative functions of cell cycle regulators, cell cycle-independent roles of CDK inhibitors in stem cell biology, molecular relationships between reprogramming and cancer, and development of new therapeutic tools in advanced cancer.
